Myriad Genetics, Inc.
Status: Publicly traded
Direct answer
Myriad Genetics, Inc. is publicly traded on NASDAQ under the ticker MYGN.
Myriad Genetics, Inc. is a leading company specializing in genetic testing and precision medicine. The firm focuses on developing and marketing a wide array of genetic diagnostic solutions across both domestic U.S. and international landscapes. Their extensive diagnostic offerings cater to crucial medical fields, including oncology, women's health, and mental well-being. In cancer diagnostics, Myriad provides...
Can you invest in Myriad Genetics, Inc.?
Yes. Myriad Genetics, Inc. trades publicly on NASDAQ as MYGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Myriad Genetics, Inc.
Detailed equity research is provided by MarketSnap.